Literature DB >> 17522337

Case study of intracerebral plasmacytoma as an initial presentation of multiple myeloma.

Aurelia Wavre1, Audrey S Baur, Michael Betz, Dominique Mühlematter, Martine Jotterand, Khalil Zaman, Nicolas Ketterer.   

Abstract

Cerebral involvement is an uncommon complication of multiple myeloma. We report on a 64-year-old man hospitalized for a partial seizure. MRI showed two intracerebral lesions, which proved to be plasmacytomas. After complete staging, we retained the diagnosis of immunoglobulin G lambda-type multiple myeloma with CNS involvement. Cytogenetic analysis of plasma cells detected a deletion in the p53 gene at 17p13.1. Despite cranial radiotherapy and systemic chemotherapy, the patient's disease progressed rapidly and he died five months after diagnosis. What makes this case unusual is that overt multiple myeloma had been absent before cerebral involvement was discovered. It confirms the extremely poor prognosis of patients with CNS myeloma even in the presence of aggressive treatment. Cytogenetic abnormalities could be a marker of chromosomal and genetic instability, conferring to multiple myeloma a more aggressive profile.

Entities:  

Mesh:

Year:  2007        PMID: 17522337      PMCID: PMC1907416          DOI: 10.1215/15228517-2007-008

Source DB:  PubMed          Journal:  Neuro Oncol        ISSN: 1522-8517            Impact factor:   12.300


  5 in total

Review 1.  Myeloma of the central nervous system: association with high-risk chromosomal abnormalities, plasmablastic morphology and extramedullary manifestations.

Authors:  Athanasios B-T Fassas; Firas Muwalla; Tanya Berryman; Riad Benramdane; Lija Joseph; Elias Anaissie; Rajesh Sethi; Raman Desikan; David Siegel; Ashraf Badros; Amir Toor; Maurizio Zangari; Christopher Morris; Edgardo Angtuaco; Sajini Mathew; Carla Wilson; Aubrey Hough; Sami Harik; Bart Barlogie; Guido Tricot
Journal:  Br J Haematol       Date:  2002-04       Impact factor: 6.998

2.  Multiple myeloma involving central nervous system: high frequency of chromosome 17p13.1 (p53) deletions.

Authors:  Hong Chang; Stephen Sloan; Dan Li; A Keith Stewart
Journal:  Br J Haematol       Date:  2004-11       Impact factor: 6.998

3.  Clinical and biologic implications of recurrent genomic aberrations in myeloma.

Authors:  Rafael Fonseca; Emily Blood; Montserrat Rue; David Harrington; Martin M Oken; Robert A Kyle; Gordon W Dewald; Brian Van Ness; Scott A Van Wier; Kimberly J Henderson; Richard J Bailey; Philip R Greipp
Journal:  Blood       Date:  2003-02-06       Impact factor: 22.113

Review 4.  Myeloma of the central nervous system: strong association with unfavorable chromosomal abnormalities and other high-risk disease features.

Authors:  Athanasios B T Fassas; Susan Ward; Firas Muwalla; Rudy Van Hemert; Keith Schluterman; Sami Harik; Guido Tricot
Journal:  Leuk Lymphoma       Date:  2004-02

5.  Presence of a p53 gene deletion in patients with multiple myeloma predicts for short survival after conventional-dose chemotherapy.

Authors:  J Drach; J Ackermann; E Fritz; E Krömer; R Schuster; H Gisslinger; M DeSantis; N Zojer; M Fiegl; S Roka; J Schuster; R Heinz; H Ludwig; H Huber
Journal:  Blood       Date:  1998-08-01       Impact factor: 22.113

  5 in total
  10 in total

1.  Solitary dural plasmacytoma with parenchymal invasion.

Authors:  R Pour Khalili; M Mokhtari; S Abbasi Fard; A Neshat; R Norouzi
Journal:  Asian J Neurosurg       Date:  2015 Apr-Jun

2.  Intracranial mass of multiple myeloma with good response to chemotherapy.

Authors:  Nathalie E Synhaeve; Cees van der Heul; Cees C Tijssen
Journal:  BMJ Case Rep       Date:  2012-09-30

3.  Multiple myeloma presenting as spinal cord compression: a case report.

Authors:  Chayan Chakraborti; Kristen L Miller
Journal:  J Med Case Rep       Date:  2010-08-06

Review 4.  Intracranial involvement in plasmacytomas and multiple myeloma: a pictorial essay.

Authors:  Alfonso Cerase; Annachiara Tarantino; Alessandro Gozzetti; Carmine Franco Muccio; Paola Gennari; Lucia Monti; Arturo Di Blasi; Carlo Venturi
Journal:  Neuroradiology       Date:  2008-05-31       Impact factor: 2.804

5.  Successful Treatment of Posttransplant EBV-Associated Lymphoma and Plasmacytoma Solely Localized to the CNS.

Authors:  Per Boye Hansen; Signe Ledou Nielsen
Journal:  Case Rep Hematol       Date:  2012-02-28

6.  Cerebellar ataxia and sensory ganglionopathy associated with light-chain myeloma.

Authors:  Panagiotis Zis; Dasappaiah Ganesh Rao; Bart E Wagner; Lucinda Nicholson-Goult; Nigel Hoggard; Marios Hadjivassiliou
Journal:  Cerebellum Ataxias       Date:  2017-01-05

7.  Intracranial Calcification Masquerading as Hemorrhage in a Patient with Multiple Myeloma Presenting with Facial Neuropathy.

Authors:  Naresh Mullaguri; Anusha Battineni; Raviteja Guddeti
Journal:  Cureus       Date:  2018-06-19

8.  Proptosis and hemiplegia as an initial manifestation of multiple myeloma.

Authors:  N Tahiliani; P Kataria; A Patel; P Kendre
Journal:  J Postgrad Med       Date:  2018 Oct-Dec       Impact factor: 1.476

9.  Multiple myeloma presenting as an unhealed extraction socket: Report of a case with brief review of literature.

Authors:  Suhasini Gotur Palakshappa; Vijay Wadhwan; Vishal Bansal; Nagaraju Kamarthi
Journal:  J Oral Maxillofac Pathol       Date:  2018 May-Aug

10.  Multiple myeloma presenting as an intracranial plasmacytoma: a case report.

Authors:  Tadashi Terada
Journal:  Cases J       Date:  2009-11-30
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.